{
    "2018-10-16": [
        [
            {
                "time": "2018-10-17",
                "original_text": "Pre-Market Earnings Report for October 17, 2018: ABT, USB, ASML, MTB, NTRS, MTG, UNF, UBSH, BMI, WGO",
                "features": {
                    "keywords": [
                        "Earnings",
                        "Pre-Market",
                        "ABT",
                        "USB",
                        "ASML"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "finance",
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-10-17",
                "original_text": "Abbott Laboratories Q3 Earnings Preview",
                "features": {
                    "keywords": [
                        "Abbott",
                        "Laboratories",
                        "Q3",
                        "Earnings"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-10-17",
                "original_text": "Can Abbott's (ABT) Steady Overall Growth Aid Q3 Earnings?",
                "features": {
                    "keywords": [
                        "Abbott",
                        "Steady",
                        "Overall",
                        "Growth",
                        "Q3",
                        "Earnings"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-10-17",
                "original_text": "Barclays says to buy this name in medical tech",
                "features": {
                    "keywords": [
                        "Barclays",
                        "buy",
                        "medical",
                        "tech"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare",
                        "technology"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-10-17",
                "original_text": "What to Expect from Medtronicâ€™s Diabetes Segment",
                "features": {
                    "keywords": [
                        "Medtronic",
                        "Diabetes",
                        "Segment"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-10-17",
                "original_text": "[$$] The Strategies AbbVie Employed to Protect Humira From Copycats",
                "features": {
                    "keywords": [
                        "AbbVie",
                        "Strategies",
                        "Protect",
                        "Humira",
                        "Copycats"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            }
        ]
    ]
}